A Case of ALK-Rearranged Combined Lung Adenocarcinoma and Neuroendocrine Carcinoma with Diffuse Bone Metastasis and Partial Response to Alectinib

We report a rare case of stage IV pulmonary combined large-cell neuroendocrine carcinoma (LCNEC) and adenocarcinoma (ACA), both demonstrating anaplastic lymphoma kinase (<i>ALK</i>) rearrangement by IHC and FISH. This 61-year-old lifelong nonsmoking Asian woman presented with a cough, an...

Full description

Bibliographic Details

Published in:	Current Oncology
Main Authors:	Chloe A. Lim, Norbert Banyi, Tracy Tucker, Diana N. Ionescu, Barbara Melosky
Format:	Article
Language:	English
Published:	MDPI AG 2022-02-01
Subjects:	neuroendocrine adenocarcinoma driver mutation ALK LCNEC
Online Access:	https://www.mdpi.com/1718-7729/29/2/72